CMBA
PAHC icon

C.M. Bidwell & Associates’s Phibro Animal Health PAHC Stock Holding History

C.M. Bidwell & Associates’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$90.7K Sell
1,639
-496
-23% -$23.6K 0.04% 184
2025
Q4 		$79.8K Buy
2,135
+2,020
+1,757% +$82K 0.04% 202
2025
Q3 		$4.65K Buy
+115
New +$3.8K ﹤0.01% 338

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

C.M. Bidwell & Associates's PAHC Position: Q1 2026 in Review

C.M. Bidwell & Associates reduced its Phibro Animal Health (PAHC) stake by 23% in Q1 2026, selling an estimated $23.6K and leaving 1,639 shares worth $90.7K. The position accounts for 0.04% of the portfolio, ranked #184.

C.M. Bidwell & Associates first reported a position in PAHC in Q3 2025 and has held it in 3 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • C.M. Bidwell & Associates held 1,639 shares of Phibro Animal Health worth $90.7K as of Q1 2026.
  • C.M. Bidwell & Associates sold 496 Phibro Animal Health shares in Q1 2026, an estimated $23.6K.
  • Phibro Animal Health made up 0.04% of C.M. Bidwell & Associates's portfolio in Q1 2026, its #184 holding.
  • C.M. Bidwell & Associates first reported a position in Phibro Animal Health in Q3 2025 and has held it in 3 quarters since.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.